Navigation Links
Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy
Date:5/19/2013

ORLANDO, Fla., May 19, 2013 /PRNewswire/ -- The non-surgical Stretta® procedure employing low power and low temperature radiofrequency (RF) energy is effective in control of gastroesophageal reflux disease (GERD), and eliminates or reduces the need for medication 10 years post-procedure, according to an independent, prospective long-term assessment presented today at the Digestive Disease Week (DDW) meeting May 18-21, 2013 in Orlando, Florida.

"The sustained improvement in GERD-HRQL scores and patient satisfaction, coupled with the potential for protection against esophageal cancer validate the long-term usefulness of this safe, clinically effective and economically effective endoscopic procedure," said principal investigator Mark Noar , M.D., Director, Endoscopic Microsurgery Associates, Maryland.  "Of the 99 study participants with refractory GERD followed for 10 years, 41 percent no longer required the PPI medications they were taking pre-Stretta."

Approximately 20 percent of Americans suffer the symptoms of GERD – frequent heartburn or acid reflux, burning sensation in the chest or throat or regurgitation – at least once a week, according to the National Institutes of Health.   

In some adults with GERD, atypical symptoms may present, such as dry cough, asthma, or trouble swallowing rather than, or in addition to heartburn.

Some 12 million Americans who do not respond to conservative GERD management – dietary changes or drug treatment – could potentially benefit from the Stretta procedure, including those with the atypical manifestations.

10-Year Post-Stretta Data Conclusions:  

  • Statistically significant and sustained improvement in GERD as measured by HQRL scores, patient satisfaction, and reduced medication requirements
  • Patients with variant anatomy and prior Nissen fundoplication (anti-reflux surgery) responded as well as those with normal anatomy
  • Demonstrable improvement in Barrett's tissue, and in some cases disappearance of metaplasia and dysplasia
  • The reduction in reflux as a result of the Stretta procedure may protect against esophageal cancer
  • The 10 year results compare favorably with the results of more invasive Nissen surgery, particularly when considering the substantially reduced risk of complications with Stretta versus all anti-reflux surgery methods

SAGES Gives Stretta Its Strongest Recommendation

The Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) recently issued new Clinical Guidelines that give Stretta therapy for the treatment of GERD its highest recommendation based on strong clinical evidence from 32 clinical trials.

"This 10 year data adds to the already robust body of long term and Level 1 data for Stretta," said Will Rutan , CEO of Mederi Therapeutics. "This extremely long-term follow up confirms what was noted in the recent SAGES guidelines for GERD treatment…that Stretta is a very safe and very effective treatment whose time has come."

Stretta Reimbursement

Stretta is currently covered by Medicare in 12 states, nationwide by Tricare and the VA Systems, and locally by select commercial insurance carriers.  Together they insure more than 36 million Americans.

Poster SU1627
DDW booth # 765

About Mederi Therapeutics

Greenwich, Connecticut-based Mederi Therapeutics manufactures and markets innovative medical devices that deliver low power, low temperature radiofrequency energy (RF) to treat digestive diseases. With recently released second generation technology, Stretta for GERD and Secca for Bowel Incontinence, featuring enhancements in safety and ease of use, are ultra-minimally invasive outpatient treatments that deliver RF to the sphincter muscles at either end of the digestive system.  These therapies bridge the gap between conservative or drug therapy and invasive surgery or implants – offering effective and less complicated, and less costly alternatives.  Stretta and Secca provide durable relief to symptoms and are strongly backed by numerous clinical studies showing safety and long-term effectiveness.  Products are available in North America, South America, Europe, the Middle East and Asia.


'/>"/>
SOURCE Mederi Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Flexpoint Receives Purchase Order for Medical Device Used in Procedure Performed Millions of Times Annually
2. Angioslide Announces First Successful Below-The-Knee Procedures in the US
3. GP Strategies Partners with ATR, Inc. to Provide Advanced Procedure Improvement Technology Solutions to the Process Industry
4. Endoscopy Devices Market to 2018 - Demand for Cost-Effective, Minimally Invasive Procedures and Reimbursement for New Indications to Increase Uptake
5. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
6. Da Vinci Robot May Cause Serious Complications for Patients Receiving Hysterectomies and Other Procedures, Reports Surgical News
7. Three New Procedures Introduced At The Gateway Aesthetic Institute
8. Computer-navigated total knee replacement provides no advantage over traditional surgical procedure
9. Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Manufacturers
10. Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
11. Breakthrough Procedure Provides Relief for Acid Reflux
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, 2016 ... mobile pulmonary function testing company, is now able to perform sophisticated ... by ndd Medical Technologies , Inc. Patients ... hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients ... get any needed testing done in the comfort of her own ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping ... fitness app. The fitness app plans to fix the two major problems leading the fitness ... size fits all type program , They don’t eliminate all the reasons people ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
Breaking Medicine News(10 mins):